ACAD Stock Price Prediction 2026-2027
AI-powered forecast for ACADIA Pharmaceuticals Inc
Based on fundamental analysis and historical trends
Current Price
$0.00
Price Targets for 2027
Bear Case
$0.00
NaN%
Base Case
$0.00
NaN%
Bull Case
$0.00
NaN%
Prediction Tracking
Coming Soon for ACAD
Tracking begins January 2026
We are building a comprehensive track record of our AI predictions. Check back to see how our forecasts perform against actual results.
Upcoming Events for ACAD
Key Factors Influencing ACAD Stock
Bullish Factors
- Market position and competitive advantages
Risk Factors
- Market volatility and macroeconomic factors
- Competitive pressures in Biotechnology
Prediction Methodology
These predictions are generated using fundamental analysis including:
- P/E Ratio: 15.3x
Limited analyst coverage available. Consider viewing more research before making investment decisions.
Get Real-Time Analysis
Access live data, AI insights, and detailed valuations for ACAD
Frequently Asked Questions
What is ACAD stock price today?
Visit our real-time dashboard for the current ACAD stock price and live market data.
Is ACAD stock going up or down today?
ACAD stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy ACAD stock now?
The decision to buy ACAD depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is ACAD a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for ACAD based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is ACAD stock overvalued or undervalued?
ACAD currently trades at a P/E ratio of 15.29 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if ACAD is fairly priced.
What is ACAD's P/E ratio?
ACAD has a price-to-earnings (P/E) ratio of 15.29, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is ACAD's market cap?
ACAD (ACADIA Pharmaceuticals Inc) has a market capitalization of $3.51 billion, making it a small-cap stock.
What is ACAD's price to book ratio?
Price-to-book ratio for ACAD is available on our dashboard along with other valuation metrics.
Does ACAD pay dividends?
ACAD does not currently pay dividends. Many growth companies reinvest profits into the business rather than paying dividends.
What is ACAD's dividend yield?
ACAD does not currently pay dividends or dividend data is not available. Check our dashboard for the latest information.
Is ACAD stock a good long-term investment?
ACAD's long-term investment potential depends on sustainable competitive advantages, revenue growth, profitability, management quality, and industry dynamics. Our AI analysis evaluates these factors to assess long-term prospects.
What is ACAD's revenue growth rate?
Revenue growth data for ACAD is available on our dashboard with detailed financial statement analysis.
Is ACAD profitable?
Profitability metrics for ACAD are available on our dashboard with complete income statement analysis.
What are the risks of investing in ACAD?
Key risks for ACAD include market volatility, competitive pressures, regulatory changes, economic conditions, execution risks, and company-specific factors. Our AI analysis identifies material risks and their potential impact on valuation.
How does ACAD compare to its competitors?
Compare ACAD to industry peers on our dashboard using metrics like P/E ratio, revenue growth, profit margins, market share, and valuation multiples. Competitive analysis helps contextualize ACAD's performance and positioning.
What is ACAD's stock price target for 2026?
Visit our prediction page for AI-powered price targets for ACAD with bull, base, and bear case scenarios.
What do analysts say about ACAD?
Wall Street analysts provide ratings (buy/hold/sell) and price targets for ACAD. Our dashboard aggregates analyst consensus, target prices, and recent upgrades/downgrades to help you understand professional sentiment.
When is ACAD's next earnings report?
ACAD reports earnings quarterly. Check our dashboard for the upcoming earnings date, analyst estimates for revenue and EPS, and historical earnings performance. Earnings reports often drive significant stock price movements.